As an extensive differentially expressed gene in 13 cancer types, a high level of TOP2A expression has been indicated in multiple cancers, including high-grade serous ovarian cancer, hepatocellular carcinoma, esophageal squamous cell carcinoma [23–25]. Here, TOP2A is linked to ovarian serous adenocarcinoma.